RPC, Provista Sign 5-Year Laboratory Services Agreement
Radient Pharmaceuticals Corporation has entered into an exclusive 5-year laboratory services agreement with Provista Diagnostics Inc.
Read MoreSearch Results for: lung cancer
GE Healthcare to Acquire Clarient Inc
Posted by Clinical Lab Products | Oct 25, 2010 | Cancer, Miscellaneous |
GE Healthcare, a unit of General Electric Company, and Clarient Inc announced have entered into a definitive agreement for GE Healthcare to acquire Clarient.
Read MoreStudy Details Gene Signature Used by LungExpress Dx
Posted by Clinical Lab Products | Sep 16, 2010 | Cancer, Miscellaneous |
Med BioGene Inc announced the publication of a study detailing the development and validation of the 15-gene signature used by LungExpress Dx entitled “Prognostic and Predictive Gene Signature for Adjuvant Chemotherapy in Resected Non-Small-Cell Lung Cancer”.
Read MoreRadient Pharmaceuticals Announces Its 2010 Onko-Sure Reference Guide
Posted by Clinical Lab Products | Aug 26, 2010 | Cancer, Miscellaneous |
Radient Pharmaceuticals Corp (RPC) announced broad availability of its 2010 Onko-Sure Reference Guide for the Company’s USFDA-approved Onko-Sure in vitro diagnostic (IVD) cancer test kit.
Read MoreResearch and Markets Report Delves into Lung Cancer Test Development
Posted by Clinical Lab Products | Aug 16, 2010 | Cancer, Miscellaneous |
Research and Markets has announced the addition of the “The Top 20 Developers of Molecular Diagnostic Tests for Lung Cancer” report to their offering.
Read More